BIMI Holdings EBIT Margin 2010-2023 | BIMI
Current and historical EBIT (Earnings Before Interest & Taxes) margin for BIMI Holdings (BIMI) over the last 10 years. The current EBIT profit margin for BIMI Holdings as of September 30, 2023 is .
| BIMI Holdings EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2023-09-30 | $0.01B | $-0.01B | -69.23% |
| 2023-06-30 | $0.02B | $-0.01B | -53.33% |
| 2023-03-31 | $0.01B | $-0.01B | -100.00% |
| 2022-12-31 | $0.01B | $-0.02B | -125.00% |
| 2022-09-30 | $0.01B | $-0.03B | -485.71% |
| 2022-06-30 | $0.02B | $-0.03B | -212.50% |
| 2022-03-31 | $0.02B | $-0.03B | -140.91% |
| 2021-12-31 | $0.02B | $-0.03B | -152.38% |
| 2021-09-30 | $0.03B | $-0.00B | -12.90% |
| 2021-06-30 | $0.02B | $-0.00B | -15.00% |
| 2021-03-31 | $0.02B | $-0.01B | -33.33% |
| 2020-12-31 | $0.01B | $-0.00B | -23.08% |
| 2020-06-30 | $0.00B | $-0.00B | -75.00% |
| 2020-03-31 | $0.00B | $-0.00B | inf% |
| 2019-06-30 | $0.00B | $0.00B | 100.00% |
| 2018-09-30 | $0.01B | $-0.00B | -28.57% |
| 2018-06-30 | $0.01B | $-0.00B | -28.57% |
| 2018-03-31 | $0.01B | 0 | 0.00% |
| 2017-12-31 | $0.01B | 0 | 0.00% |
| 2017-09-30 | $0.01B | $-0.00B | -16.67% |
| 2017-06-30 | $0.01B | $-0.00B | -16.67% |
| 2017-03-31 | $0.01B | $-0.00B | -20.00% |
| 2016-12-31 | $0.01B | $-0.00B | -16.67% |
| 2016-09-30 | $0.01B | $-0.00B | -16.67% |
| 2016-06-30 | $0.01B | $-0.00B | -12.50% |
| 2016-03-31 | $0.01B | $-0.00B | -12.50% |
| 2015-12-31 | $0.01B | $-0.00B | -14.29% |
| 2015-09-30 | $0.01B | $-0.00B | -11.11% |
| 2015-06-30 | $0.01B | $-0.00B | -11.11% |
| 2015-03-31 | $0.01B | $-0.00B | -10.00% |
| 2014-12-31 | $0.01B | $-0.00B | -9.09% |
| 2014-09-30 | $0.01B | 0 | 0.00% |
| 2014-06-30 | $0.01B | 0 | 0.00% |
| 2014-03-31 | $0.01B | 0 | 0.00% |
| 2013-12-31 | $0.01B | 0 | 0.00% |
| 2013-09-30 | $0.01B | 0 | 0.00% |
| 2013-06-30 | $0.01B | 0 | 0.00% |
| 2013-03-31 | $0.01B | 0 | 0.00% |
| 2012-12-31 | $0.01B | 0 | 0.00% |
| 2012-09-30 | $0.01B | $0.00B | 9.09% |
| 2012-06-30 | $0.01B | $0.00B | 8.33% |
| 2012-03-31 | $0.01B | $0.00B | 14.29% |
| 2011-12-31 | $0.02B | $0.00B | 12.50% |
| 2011-09-30 | $0.02B | $0.00B | 11.11% |
| 2011-06-30 | $0.02B | $0.01B | 21.74% |
| 2011-03-31 | $0.03B | $0.01B | 24.00% |
| 2010-12-31 | $0.03B | $0.01B | 28.00% |
| 2010-09-30 | $0.02B | $0.01B | 34.78% |
| 2010-06-30 | $0.02B | $0.01B | 34.78% |
| 2010-03-31 | $0.02B | $0.01B | 33.33% |
| 2009-12-31 | $0.02B | $0.01B | 30.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.013B | $0.012B |
| BIMI Holdings Inc. is a healthcare products and services provider, offering a broad range of healthcare products and related services principally in the U.S. and Asia. BIMI Holdings Inc., formerly known as BIMI International Medical Inc., is based in New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.220B | 15.71 |
| Cencora (COR) | United States | $44.462B | 17.33 |
| ICON (ICLR) | Ireland | $25.533B | 24.10 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| Avantor (AVTR) | United States | $16.499B | 24.29 |
| CochLear (CHEOY) | Australia | $14.039B | 0.00 |
| Viatris (VTRS) | United States | $13.526B | 4.04 |
| Revvity (RVTY) | United States | $13.024B | 22.85 |
| Natera (NTRA) | United States | $12.689B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.061B | 39.68 |
| Charles River Laboratories (CRL) | United States | $11.765B | 22.53 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.621B | 0.00 |
| Solventum (SOLV) | United States | $10.905B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.566B | 0.00 |
| HealthEquity (HQY) | United States | $6.637B | 49.59 |
| Organon (OGN) | United States | $5.385B | 5.11 |
| Bausch + Lomb (BLCO) | Canada | $5.192B | 20.80 |
| Doximity (DOCS) | United States | $4.289B | 31.93 |
| PACS (PACS) | United States | $3.766B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.289B | 30.09 |
| Sotera Health (SHC) | United States | $3.221B | 15.81 |
| Life Times (LTH) | United States | $2.927B | 30.67 |
| GoodRx Holdings (GDRX) | United States | $2.646B | 95.71 |
| Progyny (PGNY) | United States | $2.609B | 44.92 |
| Premier (PINC) | United States | $2.362B | 8.84 |
| AMN Healthcare Services Inc (AMN) | United States | $2.242B | 8.89 |
| Agilon Health (AGL) | United States | $2.143B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.111B | 0.00 |
| NovoCure (NVCR) | Jersey | $1.935B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.926B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.546B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.323B | 0.00 |
| Embecta (EMBC) | United States | $0.818B | 5.56 |
| CareDx (CDNA) | United States | $0.780B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.718B | 7.62 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Auna S.A (AUNA) | Luxembourg | $0.655B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.611B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.555B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.524B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| Enhabit (EHAB) | United States | $0.433B | 43.20 |
| MultiPlan (MPLN) | United States | $0.412B | 0.00 |
| LifeMD (LFMD) | United States | $0.403B | 0.00 |
| ModivCare (MODV) | United States | $0.378B | 7.08 |
| Beauty Health (SKIN) | United States | $0.338B | 0.00 |
| DocGo (DCGO) | United States | $0.329B | 17.56 |
| Sera Prognostics (SERA) | United States | $0.295B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.267B | 0.00 |
| Sharecare (SHCR) | United States | $0.257B | 0.00 |
| Biodesix (BDSX) | United States | $0.174B | 0.00 |
| So-Young (SY) | China | $0.129B | 43.33 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| Oncology Institute (TOI) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| NeueHealth (NEUE) | United States | $0.050B | 6.74 |
| Nutex Health (NUTX) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.022B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |